ATGAM conc perf 250 mg/5ml 5 amp 5 ml
7680688240016
CH-68824
L04AA03
07.15.0.
Reimbursement limitations:
ATGAM.01
Atgam est remboursé chez l’adulte et l’enfant âgé de 2 ans et plus pour le …
1 / 3
google
Details
- Product number
- 6882401
- CPT
- -
- Packaging group
- 5 x 5 ml
- Unit
- Ampulle(n)
- Composition
- immunoglobulinum anti-T limphocytorum ex equus 50 mg, glycinum, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Atgam 250 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
5 x 5 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 3058.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2025
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 68824
- Drug name
- Atgam, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 21/09/2023
- Authorization expiration date
- 20/09/2028
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ATGAM conc perf 250 mg/5ml 5 amp 5 ml
- Description (DE)
- ATGAM Inf Konz 250 mg/5ml 5 Amp 5 ml
- Market launch
- 21/09/2023
- Narcotic (BTM)
- No